S. Koch
Molecular Biology · with Claesson‐Welsh · 2006–2012
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 32 citations into it; #15,864 of 17,773 by trust here, #12,465 by citations
- Cell Biology — 9 citations into it
- Immunology and Allergy — 8 citations into it
Whom S. Koch trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Koch overall
Papers from S. Koch's perspective
Ordered by how strongly the researchers S. Koch trusts endorse each paper. Same corpus, a different order for every researcher.
- A model for gene therapy of human hereditary lymphedema (Proceedings of the National Academy of Sciences of the United States of America)
- Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
- VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. (Cell)
- Autocrine VEGF signaling is required for vascular homeostasis. (Cell)
- Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability (Proceedings of the National Academy of Sciences of the United States of America)
- Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins (Nature Immunology)
- Focal adhesion kinase: the first ten years (Journal of Cell Science)
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (Cancer Cell)
- Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 (Nature Medicine)
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions (Nature Medicine)
Their papers
- Signal transduction by vascular endothelial growth factor receptors. (2012) — 1,159 citations
- Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). (2006) — 741 citations